Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA1 | P15085 | 2/20 | 0.41 |
| ▸ | CPA3 | P15088 | 2/20 | 0.41 |
| ▸ | CPB1 | P15086 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.36 |
| ▸ | MMP2 | P08253 | 6/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | MMP12 | P39900 | 1/20 | 0.35 |
| ▸ | LTA4H | P09960 | 2/20 | 0.34 |
| ▸ | MMP3 | P08254 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13042934 | 0.84 | CPA1 (0.37) | CPA1CPA3CPB1CPB2FOLH1 | |
| SCHEMBL13756261 | 0.83 | FOLH1 (0.47) | CPA1CPA3CPB1CPB2FOLH1 | |
| SCHEMBL16328599 | 0.82 | CPA1 (0.35) | CPA1CPA3CPB1CPB2FOLH1 | |
| SCHEMBL13042904 | 0.81 | MMP12 (0.34) | CPA1CPA3CPB1CPB2MMP2 | |
| SCHEMBL786932 | 0.80 | FOLH1 (0.44) | CPA1CPA3CPB1CPB2FOLH1 | |
| SCHEMBL13151579 | 0.79 | FOLH1 (0.43) | CPA1CPA3CPB1CPB2FOLH1 | |
| SCHEMBL21066683 | 0.78 | CPA1 (0.43) | CPA1CPA3CPB1CPB2FOLH1 | |
| SCHEMBL786957 | 0.78 | MME (0.37) | LTA4H | |
| SCHEMBL786883 | 0.77 | CA2 (0.44) | FOLH1MMP2MMP9MMP12MMP3 | |
| SCHEMBL15761478 | 0.77 | FFAR1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8425803-B2 | Nanocrystal doped matrixes | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-04-23 | — | — | US | disclosed |
| US-8283412-B2 | Functionalized matrices for dispersion of nanostructures | NANOSYS, INC. (US) | 2012-10-09 | — | — | US | disclosed |
| US-20100276638-A1 | Functionalized matrixes for dispersion of nanostructures | NANOSYS, INC. (US) | 2010-11-04 | — | — | US | disclosed |
| US-20100140551-A1 | Nanocrystal doped matrixes | NANOSYS, INC. (US) | 2010-06-10 | — | — | US | disclosed |
| US-7645397-B2 | Luminescent nanocomposite of luminescent nanocrystalline embedded in an epoxy, polyurea, or polyurethane matrix; retain luminescence; surfaces of nanocrystals having bound ligands comprising dicarboxylic acid moiety or aliphatic or polymeric amines; high efficiency solid-state white lighting; optics | NANOSYS, INC. (US) | 2010-01-12 | — | — | US | disclosed |
| US-20070034833-A1 | Luminescent nanocomposite of luminescent nanocrystalline embedded in an epoxy, polyurea, or polyurethane matrix; retain luminescence; surfaces of nanocrystals having bound ligands comprising dicarboxylic acid moiety or aliphatic or polymeric amines; high efficiency solid-state white lighting; optics | NANOSYS, INC. | 2007-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100276638-A1 | Functionalized matrixes for dispersion of nanostructures | STRA6, EPHA6, MIF | CPA1 2831/4885CPA3 1731/4885CPB1 2695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.